Press

France’s Gustave Roussy Institute, Europe's leading cancer center and ranked third in the world according to Newsweek Ma...

Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient’s clinical chara...

Synapse Medicine has raised $28 million, led by leading European venture firm Korelya Capital, and past investors (XAnge...

Synapse Medicine, the leading Medication Intelligence technology, announces a partnership on medication reconciliation w...

Synapse Medicine, which was founded by public health physicians, rolls out its Medication Shield technology to increase ...

Synapse Medicine has announced that it has raised 8 million dollars, spearheaded by the MACSF, a leading insurance provi...